© Versita Sp. z o.o. In the present study a reversed phase high performance liquid chromatography (RP-HPLC) method with diode array detector (DAD) at room temperature was used for obtaining impurity profiles of 20 drug products containing simvastatin as an active substance. Fouriertransform infrared spectroscopy (FT-IR) was carried out to obtain absorption spectra of samples. The partial least squares (PLS) model was built to predict the relative content of lovastatin, the main impurity of simvastatin, and sum of statin-like impurities. In order to build the PLS model, peak areas obtained from HPLC chromatograms were related to FT-IR spectra of drugs. The PLS model based on signal normal variate and orthogonal signal correction (SNV+OSC) transformed FT-IR spectra was able to predict the content of drug impurities in real samples with a good prediction ability (R 2 > 0.95).
Introduction
One of the most important features of pharmaceutical products should be their high quality, which means meeting official standards for strength, purity, packaging etc. Poor-quality pharmaceuticals can be dangerous for human health. The presence of impurities, even in small amounts, may influence the efficacy and safety of pharmaceuticals [1, 2] . Impurities are unwanted substances that may reduce the product stability and therapeutic effect or even cause toxic and genotoxic effects [2] . For these reasons, impurity profiling should be considered in assuring a high quality of drugs and safety of a drug therapy. The number and variety of impurities depend on the route and conditions of the synthesis and several other factors such as the purity of the starting materials and conditions of storage [3] . Recent papers have reported the increasing importance of impurity profiling as a significant factor in drug development and regulatory assessment [1] [2] [3] [4] .
Statins are a class of pharmaceuticals most widely used in the treatment of atherosclerosis. Moreover, recent papers have also indicated their lipid-independent pleiotropic effects [5] [6] [7] [8] . Simvastatin is the most common statin used as an active ingredient. Basniwal et al. [9] have described pharmacokinetic and pharmacodynamics aspects of simvastatin, including metabolic pathways, adverse effects and drug interactions. This review [9] also takes account of chemistry, different possible impurities and all the reported methods for the synthesis
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Evaluation of impurities in simvastatin drug products with the use of FT-IR spectroscopy and selected chemometric techniques and determination of simvastatin. Simvastatin can be obtained in several synthesis pathways. During synthesis, besides the main reaction that produces simvastatin, there are also unwanted side reactions responsible for impurities. Qualitative and quantitative composition of these impurities is related to the pathway and conditions of synthesis. For example, simvastatin can be synthesized from lovastatin, which is the main impurity of the simvastatin products [10] . A large number of various analytical methods for determination of simvastatin and its impurities have been described [11] [12] [13] [14] [15] [16] .
High performance liquid chromatography (HPLC) is undoubtedly the most frequently used and successful method in drug impurity profiling [17] [18] [19] . The main advantage of the chromatographic technique is a good separation of impurities, even in multi-component samples. Unfortunately, sample preparation for chromatographic analysis is often time-consuming. As a consequence, a new approach in the development of impurity profiling methods could consider the use of spectroscopic methods coupled with chemometrics instead chromatographic techniques. Optical methods (for example FT-IR spectroscopy) are considered as rapid, low-cost analytical techniques but in the context of separation and identification of drug impurities, they cannot be applied directly. Due to these reasons, the possibility of the application of chemometric techniques, especially multivariate regression, in impurity profiling have been discussed in our study.
Chemometric techniques seem to be indispensable in extraction of chemical information from complex data sets. In the present study, the focus is on chemometric evaluation of impurities combined with infrared spectroscopy. This approach could be used to improve and simplify the quality control methods of drug products especially during manufacturing process. According to the recommendations of Food and Drug Administration and European Medicines Agency, in the pharmaceutical industry attention needs to be focused on so called process analytical technology (PAT). According to the PAT concept, production process should be improved by application of faster and more direct analytical techniques (for example infrared spectroscopy) which can be used on-line to monitor the manufacturing processes and control quality of pharmaceuticals. Thus, in this paper the usefulness of infrared spectroscopy combined with selected chemometric techniques in analysis of impurity profiles of drug products is discussed. This paper presents the results of preliminary scientific research. The simvastatin drug products, which are widely used in the treatment of atherosclerosis, have been selected for analysis as a sample material. The partial least squares algorithm was used to create calibration models for prediction of the level of lovastatin (the main impurity of simvastatin) and sum of statin-like impurities based on infrared spectra. In this paper, a combination of IR spectroscopy (as a rapid non-destructive technique requiring minimal sample preparation) with chemometric analysis is considered as a potentially useful screening tool for fast monitoring of drug product quality. A quick verification of the drug product quality (based on IR spectra and calibration model) at the stage of production process would allow to eliminate formulations that do not meet the quality criteria.
Experimental procedure

Materials and instrumentation
20 samples of simvastatin-containing drug formulations from 13 different pharmaceutical companies registered on the pharmaceutical market in Poland were analyzed. The commercial simvastatin formulations are given in Table 1 .
The chromatographic measurements were made with the use of HPLC (Shimadzu) system equipped with DAD detector. For HPLC analysis reversed-phase column Gemini (150 × 4.6 mm I.D., particle size 3 μm; Phenomenex) packed with octadecyl-bonded silica was used. The mobile phase consisted of acetonitrile (A) and water (B), in the appropriate volume ratio. The gradient elution was performed according to the following program (at an ambient temperature): linear gradient from 54% A to 56% A for the first 38 min, then an increase from 56% A to 80% A within 9 min, and 80% A for 4 min, then a decrease to 60% A within 2 min, and then linear gradient of A from 60% to 54% within 2 min, and 54% A for 10 min. The flow rate was 0.5 mL min -1 , injection volume was 20 μL. The total analysis time of the chromatographic runs was 65 min. The wavelength of the detector was set to 238 nm. Additionally, UV absorption spectra in the 190 -400 nm range were recorded.
FT-IR absorption spectra in range from 400 to 4000 cm -1 (with a resolution of 2 cm -1 ) were recorded on FT-IR spectrophotometer (8400S, Shimadzu). Powdered pharmaceutical product was ground with dry KBr (in ratio 1:100) in an agate mortar. The homogenous mixture weighing 100 mg was subjected to pressure in a hydraulic press to obtain sample-KBr pellet. Each recorded spectrum was the average of 30 scans and recorded with respect to KBr as reference.
Chemometric data exploration
Cluster and principal component analyses
Cluster analyses (or unsupervised pattern recognition) are applied in order to identify similar objects in a simple way, without using pre-established classes or groups [20] . In this paper, agglomerative clustering using the furthest neighbour distance was used. The distance between any two clusters is defined as the maximum of all possible pair-wise distances of samples between the two clusters; the two clusters with the minimum distance are joined together. A typical result of clustering is a hierarchical tree (dendrogram).
PCA is a variable reduction method which projects the main features of a multivariate data onto a lowdimensional space of the data structure [21] . The algorithm that calculates the PC-model finds the directions in the spectral data space, the principal components (PCs) that have the largest variations and represent the data as precisely as possible. Only a few first PCs are under investigation, because they describe the largest part of the total variance of the original data. The two first principal components form a plane, called a "map". Projecting every object onto this two-dimensional space enables the visualization of the similarities and dissimilarities of the samples. When a satisfactory PC-model has been found, it is possible to classify an unknown sample, i.e., a sample that was not involved in the training of the model, and get an indication to which class this new sample belongs. When the relation between variables and PCs is crucial to analysis, loading vectors can be viewed instead of score vectors. Loadings show how much each variable contributes to each PC. Loading plots are valuable for interpretation especially when compared to their corresponding score plots. A graphical display of such plots are so-called biplots.
It is well-known in chemometric analysis that the proper data pre-treatment (centring, normalization etc.) is crucial for the outcome of the result. Therefore, it is advisable to try different variants of data transformation. In this study, the procedures of centring data and the standarization techniques such as Standard Normal Variate (SNV) for IR spectra were applied. SNV transformation is a path length variation correction method that corrects each spectrum by subtracting the mean and dividing it by the standard deviation.
Regression by Partial Least Squares method
Often, the data analysis is a combination of classification and quantitative modelling. The first objective is to find the class of an object and next to obtain a prediction of values of relevant quantitative property variables. Regression methods such as PLS are suitable tools for this type of analysis. The theoretical background for PLS has been widely described in literature and can be found for example in [20, 22] . The principle of PLS modelling in application to spectral data, collected in the X-matrix, is based on a projection technique similar to PCA. The objective is to find the specific directions in the data space (so-called latent variables, LV) that best describe the relevant variations present in the spectra and, at the same time, have maximal correlation with the quantitative variables, collected in a Y-matrix, e.g. concentrations of sample constituents. In the model building phase, the number of significant latent variables (PLS components) has to be determined for each calibration model. Crossvalidation approach is the most reliable. Two statistical parameters such as root mean square error of calibration (RMSEC) and root mean square error of cross-validation (RMSECV) are then calculated. It is commonly accepted that the number of PLS components giving a minimum RMSECV is the proper number of latent variables for the model that gives optimal prediction. Additionally, regression diagnostics is often based on other statistical parameters, mainly on the coefficient of multiple determination (R 2 ). Besides, a proper number of PLS components can be inferred on the basis of the analysis The application of the PLS regression to a fullspectrum, the so-called global model, does not always provide an optimal model. The spectra can include regions that contain no relevant information for the parameter to be predicted. Many solutions of different degrees of complexity have been proposed for selecting invariant parts of the spectra. Uninformative variable selection by partial least squares, (UVE-PLS), described by Centner et al. [25] , has become a popular method for this purpose. The algorithm detects and eliminates from the PLS model those variables that do not carry any relevant information to the model by adding artificial noise to spectra and examine the predictive importance of the spectral variables in relation to the added noise. Parts of the spectra are selected when they have more importance than the added artificial noise. The advantage of the UVE-PLS approach is that we do not have to possess the information on structure, concentration etc. of sample constituents.
When the PLS analysis of the training set of spectral data with their quantitative response values is finished, the calculated model can be used to predict the unknown response values which have not been used when constructing the model collected in the test set. Therefore, the predictive ability of the model is expressed in the root mean squared error of prediction (RMSEP). In this paper, for comparison purposes, all the error values are expressed in percentage error, i.e., normalised (divided) to the range of the predicted variable: RMSE(%)=RMSE/range.
Software
STATISTICA® 8.0 software (StatSoft, USA) and the Matlab® software (Mathworks Inc., Natick, MA, USA) with the PLS Toolbox (Eigenvesctor Research Inc., version 5.5.1) have been applied for multivariate data exploration and calibration. Additional manipulations on spectra, mentioned in the following sections, were performed with our own codes written in Matlab® software package.
Results and discussion
Analysis of chromatograms
Four or five chromatograms for each pharmaceutical formulation were obtained. The part of exemplary chromatogram is shown in Fig. 1 . Six impurity peaks were selected and marked with the use of symbols: A, B, C, LOV, E, F. These analytes were characterised by UV-spectra similar to simvastatin and were called as statin-like impurity peaks (see Supplementary file).
The analysis of the chromatograms showed that the analysed pharmaceuticals differed in type and number of selected impurities. However, in all chromatograms, there was a lovastatin (LOV) peak and also a peak E, probably related to epilovastatin. The peak area of each impurity was related to the same content of simvastatin (10 mg) and averaged. The data matrix for 20 analysed samples contains the relative areas of six selected peaks, which correspond to six analysed impurities. The relative level of the summarized impurities and the percentage bar chart for all impurities in analysed simvastatin formulations is displayed in Fig. 2 . The relative levels of the summarized impurities (Fig. 2a) significantly differs between products and is not strictly related to manufacturers and dose of simvastatin. As can be seen from Fig. 2b , lovastatin is the main impurity in each simvastatin product and varies between 20% to about 55% of sum of impurities.
Analysis of IR spectra
IR spectra (9-10 for each sample) which included 3735 variables were subjected to SNV transformation within the sample and the mean spectrum was calculated. Then the mean spectra were transformed by OSC filtering. Note that OSC filter removes information not related to specified reference values from spectral data. In this case, the total impurity amount (All) was a reference.
To obtain an overview of the set of data, two chemometric methods: principal component analysis (PCA) and hierarchical cluster analysis (HCA) with different variants was applied. First the PCA analysis was performed, objects were presented on the map produced by the first two principal components. As it can be seen from Fig. 3 PCA of FT-IR spectra makes it impossible to efficiently compress data with only two principal components, which presents the PC1-PC2 score plot. Simvastatin products denoted as X1 and VT1 are significantly differ from more homogeneous group located in the centre of plot. The first principal component (PC1) differentiate simvastatin formulations in relation to sum of impurities. Vastan 10 (VT1) has the highest negative value on PC1 and is characterized by the lowest level of impurities in contrast to Simvacor (SVCR1 and SVCR2) with the highest level of summarized impurities (highest positive value on PC1). The first two dimensions of the PCA explained only 70% of the total variance (PC1 and PC2 explain 44,2 % and 18,1% of variance respectively), thus in the next step a hierarchical clustering was performed on the first four principal components. Fig. 4 presents the dendrogram of the SNV+OSC corrected FT-IR spectra. Cluster analysis (CA) generates two numerous well separated groups. When comparing the information in dendrogram with that in Fig. 2 , it can be concluded that the CA probably classifies the samples according to the relative level of impurities. The samples with level of impurities below 5 × 10 6 (mAU × min) are linked together. Except for SM2 (Simgal 40), the group plotted on the top (green group) is the one with a low level of impurities.
PLS modelling
In principle, the goal of predictive modelling in this study was to calibrate the peak area of lovastatin (LOV) and all impurities (All). In order to build reliable and predictive models, the set of FT-IR spectra for 20 samples after SNV transformation was randomly divided into two sets: 16 sample data for the training set and remaining 4 sample data for the external test set to evaluate the predictive power of the constructed model. The training set was then subjected to OSC correction. Table 2 shows the percentage of the cumulative variance captured by PLS models for SNV and SNV+OSC corrected data with LOV as the predicted value.
It can be seen that for the SNV transformed data, the model with only one PLS component accounts for a very low percentage of Y-variance (ca 16%). OSC preprocessing, after removing four orthogonal components for this data set, gives a calibration model for the first latent variable (LV) with a substantially better predictive ability c.a. 98% of the X-variance and c.a. 70 % of Y-variance, which are very close to the corresponding values when only SNV was applied with four latent variables. The solution given by SNV+OSC pre-processing simplifies the model and results in better prediction ability. The detection of outliers during calibration is a very important issue in increasing the predictive ability of models. The PCA model of FT-IR spectra appears to have one unusual Hotelling's T 2 value for sample VT1 (Vastan 10). However, outliers should be considered with the same caution. The outliers detection systems tend to select unique samples as the outliers; therefore, one should try and identify the cause of the outlying behaviour. On the other hand, the lack of the representativeness of the data used for model construction caused a lack of model validation. Since this sample was responsible for the lack of validation, presumably due to a relatively low amount of impurities, it was decided to omit the data in further considerations.
To assess the significance of the PLS model used to the SNV+OSC training data set a cross-validation with leave-one-out version has been applied. Fig. 5 illustrates the predictive power of the regression model constructed for lovastatin. As it can be seen in Fig. 5a , the model showed an unsatisfactory level of accuracy (R 2 c.a. 91%), therefore in the next step of analysis, the variable elimination procedure (UVE-PLS) was carried out. The predictive power of the model built on the selected variables only is shown in Fig. 5b . UVE-PLS model consists of 2 latent variables only, compared to 4 LV in the best full-spectrum PLS model, and has better predictive properties, i.e., RMSEP is less than 7%. The prediction results for two variables (sum of impurities and lovastatin) are summarised in Table 3 .
When evaluating RMSEC and RMSEP, one interesting observation can be made. The prediction results for the test set well match the results for the training set, i.e., RMSEP and RMSEC values are comparable. This suggests that the models are not over fitted. Both models show relatively high levels of accuracy, R 2 > 95%. In this case, the advantage of using a variable selection was obtaining the acceptable test set prediction errors and significant decreasing number of variables (c.a. 70 wave numbers instead of 3735). This work does not aim to provide detailed interpretation of particular absorption bands selected from the spectra. Nevertheless, the observed improvement of calibration models when variable elimination is used, incline the additional insight into the information that the spectra contain in particular spectral sub-ranges, at least for lovastatin. In Fig. 6 the mean spectrum of the training set and selected variables (wavenumbers) using UVE-PLS procedure for peak of lovastatin -LOV (triangle) modelling and wavenumbers for characteristic bands of pure lovastatin FT-IR spectrum (dots) are shown. The plot clearly shows spectral regions that are important for the purpose of a good PLS model construction and, as can be seen, they are in good agreement with lovastatin characteristic bands.
Conclusions
This paper demonstrates application of chemometric methods for the analysis of impurity profile of drug products containing simvastatin as an active ingredient. Two classification methods (CA and PCA) were applied for data set obtained with the use of FT-IR spectroscopy. It can be noticed that the analysed data set has a characteristic internal structure indicating the possibility of dividing them into two more homogenous groups according to the relative level of impurities. This study also shows that PLS is a powerful tool for modelling impurity profiles based on FT-IR spectra. The results of the UVE-PLS modelling showed that the obtained RMSEP was acceptable and the model based on SNV+OSC corrected FT-IR spectra was able to predict the content (expressed as a peak area) of drug impurities in real samples with a good prediction ability.
